Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Girling

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Human Reproduction (Oxford, England)|August 2, 2002
The effect on pregnancy rates of tubal perfusion pressure reductions achieved by guide-wire tubal catheterizationSpyros Papaioannou, Masoud Afnan, Alan J Girling, et al.
BMJ Quality & Safety|October 17, 2012
Case-mix adjusted hospital mortality is a poor proxy for preventable mortality: a modelling studyAlan J Girling, Timothy P Hofer, Jianhua Wu, et al.
Human Reproduction (Oxford, England)|August 31, 2002
Long-term fertility prognosis following selective salpingography and tubal catheterization in women with proximal tubal blockageSpyros Papaioannou, Masoud Afnan, Alan J Girling, et al.
British Journal of Haematology|April 1, 1989
Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemiaA J Keidan, M C Sowter, C S Johnson, et al.
Thorax|October 1, 1975
Survey of the sputum cytology service in England and WalesN C Oswald, K F Hinson, G Canti, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1977
Serum rifampicin concentration related to dose size and to the incidence of the 'flu' syndrome during intermittent rifampicin administrationJ M Dickinson, D A Mitchison, S K Lee, et al.
Thorax|February 5, 2004
BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112M F Muers, R M Rudd, M E R O'Brien, et al.
BMJ Quality & Safety|June 24, 2016
Reviewing deaths in British and US hospitals: a study of two scales for assessing preventabilitySemira Manaseki-Holland, Richard J Lilford, Jonathan R B Bishop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working PartyN Thatcher, P I Clark, D B Smith, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1992
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosisS L Chan, W W Yew, W K Ma, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Human Reproduction (Oxford, England)|August 2, 2002
The effect on pregnancy rates of tubal perfusion pressure reductions achieved by guide-wire tubal catheterizationSpyros Papaioannou, Masoud Afnan, Alan J Girling, et al.
BMJ Quality & Safety|October 17, 2012
Case-mix adjusted hospital mortality is a poor proxy for preventable mortality: a modelling studyAlan J Girling, Timothy P Hofer, Jianhua Wu, et al.
Human Reproduction (Oxford, England)|August 31, 2002
Long-term fertility prognosis following selective salpingography and tubal catheterization in women with proximal tubal blockageSpyros Papaioannou, Masoud Afnan, Alan J Girling, et al.
British Journal of Haematology|April 1, 1989
Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemiaA J Keidan, M C Sowter, C S Johnson, et al.
Thorax|October 1, 1975
Survey of the sputum cytology service in England and WalesN C Oswald, K F Hinson, G Canti, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1977
Serum rifampicin concentration related to dose size and to the incidence of the 'flu' syndrome during intermittent rifampicin administrationJ M Dickinson, D A Mitchison, S K Lee, et al.
Thorax|February 5, 2004
BTS randomised feasibility study of active symptom control with or without chemotherapy in malignant pleural mesothelioma: ISRCTN 54469112M F Muers, R M Rudd, M E R O'Brien, et al.
BMJ Quality & Safety|June 24, 2016
Reviewing deaths in British and US hospitals: a study of two scales for assessing preventabilitySemira Manaseki-Holland, Richard J Lilford, Jonathan R B Bishop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working PartyN Thatcher, P I Clark, D B Smith, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 1, 1992
The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosisS L Chan, W W Yew, W K Ma, et al.
Pageof 20